Lipid Abnormalities and Inflammation in HIV Inflection.

Area of Science:

• Cardiovascular Health
• Infectious Diseases
• Immunology

Background:

• HIV infection and antiretroviral therapy (ART) are linked to abnormal lipid profiles.
• Persistent inflammation in HIV, even with viral suppression, contributes to cardiovascular disease (CVD) risk.
• Pro-inflammatory lipids like oxidized LDL and HDL are elevated in HIV patients, correlating with immune activation.

Purpose of the Study:

• To investigate the complex interplay between inflammation and lipid metabolism in HIV.
• To understand how inflammation modifies lipids and how these lipids perpetuate inflammation.
• To identify mechanisms contributing to increased CVD risk in individuals with HIV.

Main Methods:

• Review of existing literature on HIV, ART, inflammation, and lipid profiles.
• Analysis of studies measuring lipid species and inflammatory markers in HIV-infected individuals.
• Exploration of the bidirectional relationship between inflammation and lipid modification.

Main Results:

• HIV and ART are associated with significant lipid profile changes.
• Inflammation plays a key role in modifying lipid composition and function.
• Elevated pro-inflammatory lipids are observed, linked to immune activation markers.

Conclusions:

• The bidirectional relationship between inflammation and lipids in HIV requires further investigation.
• Understanding these mechanisms is crucial for managing CVD risk in HIV patients.
• Clinical trials should consider the complex lipid-inflammation interactions in HIV management strategies.